Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression

Journal of Neuro-Oncology

Volumn 80, Issue 1, 2006, Pages 1-7

  Korhonen, Katariina ^a   Salminen, Tiina ^b   Raitanen, Jani ^b   Auvinen, Anssi ^b   Isola, Jorma ^c   Haapasalo, Hannu ^d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Androgen receptor; Estrogen receptor; Meningioma; MIB 1; Progesterone receptor

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN SURGERY; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER RECURRENCE; FEMALE; FINLAND; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PATHOGENESIS; PROTEIN EXPRESSION; SEX DIFFERENCE; TISSUE MICROARRAY;

AGE FACTORS; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEX FACTORS;

EID: 33749178571     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9146-9     Document Type: Article

References (52)

1. Abramovich CM, Prayson RA (1998) MIB-1 labeling indices benign, aggressive, and malignant meningiomas: A study of 90 tumors. Hum Pathol 29:1420-1427
2. Adams EF, Schrell UM, Fahlbusch R, Thierauf P (1990) Hormonal dependency of cerebral meningiomas. Part 2: in vitro effect of steroids, bromocriptine, and epidermal growth factor ofmeningiomas. J Neurosurg 73:750-755
3. KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol 32:970-975
4. Bickerstaff ER, Small JM, Guest IA (1958) The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21:89-91
5. Black P, Carroll R, Zhang J (1996) The molecular biology of hormone and growth factor receptors in meningiomas. Acta Neurochir 65(Suppl):50-53
6. Blankenstein MA, Blaauw G, Lamberts SWJ (1984) Progestin and estrogen receptors in human meningioma. Clin Neuropharmacol 7:363-367
7. Bouillot P, Pellissier JF, Devictor B, Graziani N, Bianco N, Grisoli F, Figarella-Branger D (1994) Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data. J Neurosurg 81:765-773
8. Bozzetti C, Camisa R, Nizzoli R, Manotti L, Guazzi A Naldi N, Mazza S (1995) Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation. Surg Neurol 43:230-234
9. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H (1993) Immunohistochemical detection of female sex hormone receptors in meningiomas: Correlation with clinical and histological features. Neurosurgery 33:212-218
10. Carrol RS, Glowacka D, Dashner K, Black PM (1993) Progesterone receptor expression in meningiomas. Cancer Res 53:1312-1316
11. Carrol RS, Zhang J, Dashner K, Sar M, Wilson EM, Black P (1995) Androgen receptor expression in meningiomas. J Neurosurg 82:453-460
12. Carrol RS, Zhang J, Dashner K, Black P (1995) Progesterone and glucocorticoid receptor activation in meningiomas. Neurosurgery 37:92-97
13. Carroll RS, Zhang J, Black P (1999) Expression of estrogen receptors alpha and beta in human meningiomas. J Neuro-Oncol 42:109-116
14. Carrol RS, Brown M, Zhang J, DiRenzo J, Font de Mora J, Black PM (2000) Expression of a subset of steroid receptor cofactors is associated with progesterone receptor epression in meningiomas. Clin Cancer Res 6:3570-3575
15. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363
16. Christensen HC, Kosteljanetz M, Johansen C (2003) Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 52:1327-1334
17. Custer BS, Koepsell TD, Mueller BA (2002) The associaton between breast carcinoma and meningioma in women. Cancer 94:1626-1635
18. Fewings PE, Battersby RD, Timperley WR (2000) Long-term follow-up of progesterone receptor status in benign meningioma: A prognonstic indicator of recurrence? J Neurosurg 92:401-405
19. Goodwin JW, Crowley J, Eyre HJ, Stafford B, Jaeckle KA, Townsen JJ (1993) A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: A Southwest Oncology Group study. J Neuro-oncol 15:75-77
20. Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL (1991) Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861-866
21. Hana V, Murphy LJ (1994) Interdependence of epidermal growth factor and insulin-like growth factor-I expression in the mouse uterus. Endocrinology 135:107-112
22. Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: Prognostic considerations. J Neurosurg 86:113-120
23. Hsu DW, Efird JT, Hedley-Whyte ET (1998) MIB-1 (Ki-67) index and transfoming growth factor-alpha (TGFα) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol App Neurobiology 24:441-452
24. Jhawar BS, Fuchs CS, Colditz GA, Stamper MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848-853
25. Jääskeläinen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242
26. Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140-145
27. Khalid H (1994) Immunohistochemical study of estrogen receptor related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Cancer 74:679-685
28. Kleihues P, Burger PC, Scheithauer B (1993) The new WHO classification of brain tumors. Brain Pathol 3:255-268
29. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 7:844-847
30. Konstantinidou AE, Korkolopoulou P, Mahera H, Kotsiakis X, Hranioti S, Eftychiadis C, Patsouris E (2003) Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 43:280-290
31. Lamberts SW, Tange HL, Avezaat CJ, Braakman R, Wijngaarde R, Koper JW, de Jong H (1992) Mifepristone (RU486) treatment of meningiomas. J Neurol Neurosurg Psychiat 55:486-490
32. Marks SM, Whitewell HL, Lye RH (1986) Recurrence of meningiomas after operation. Surg Neurol 25:436-440
33. Markwalder TM, Seiler RW, Zava DT (1985) Antiestrogenic therapy of meningiomas - a pilot study. Surg Neurol 24:245-249
34. Matsuda Y, Kawamoto K, Kiya K, Kurisu K, Sugiyama K, Uozumi T (1994) Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 80:527-534
35. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, et al (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504-510
36. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN (1993) Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78:456-462
37. Miller RE (1986) Breast cancer and meningioma. J Surg Oncol 31:182-183
38. Nagashima G, Aoyagi M, Wakimoto H, Tamaki M, Ohno K, Hirakawa K (1995) Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478-483
39. Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgery 53:62-71
40. Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas in autopsy study. Surg Neurol 27:319-322
41. Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J (1995) Meningioma: proliferative potential and clinicoradiological features. Neurosurgery 37:1049-1055
42. Olson JJ, Beck DW, Schlechte J, Loh P-M (1986) Hormonal manipulation of meningiomas in vitro. J Neurosurg 65:99-107
43. Oura S, Sakurai T, Yoshimura G, Tamaki T, Umemura T, Kokawa Y, et al (2000) Regression of a presumed meningioma with the antiestrogen agent mepitiostane: Case report. J Neurosurg 93:132-135
44. Perrot-Applanat M, Groyer-Picard MT, Kujas M (1992) Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir 115:20-30
45. Reynolds RK, Talavera F, Roberts JA, Hopkins MP, Menon KMJ (1990) Regulation of epidermal growth factor and insulin-like growth factor I receptors by estradiol and progesterone in normal and neoplastic endometrial cell cultures. Gynecol Oncol 38:396-406
46. Roelvinck NCA, Kamphorst W, van Alphen HAM, Rao R (1987) Pregnancy-related primary brain and spinal tumors. Arch Neurol 44:209-215
47. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M (2004) The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 57:1033-1037
48. Rubinstein AB, Loven D, Geier A, Reichental E, Gadoth N (1994) Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg 81:184-187
49. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola J, Helin HJ (1994) Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA and S-phase fraction using archival paraffin-embedded samples. J Pathol 174:275-282
50. Schoenberg BS, Christine BW, Wisnant JP (1975) Nervous system neoplasms and primary malignances of other sites. The unique association between meningiomas and breast cancer. Neurology 25:705-712
51. Schrell UMH, Adams EF, Fahlbusch R, Greb R, Jirikowski G, Prior R, Ramalho-Ortigao FJ (1990) Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73: 743-749
52. Tonn JC, Ott MM, Bouterfa H, Kerkau S, Kapp M, Müller-Hermelink HK, Roosen K (1997) Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas. Neurosurgery 41:1152-1159